Theralase Technologies Price To Sales Ratio Over Time
| TLT Stock | CAD 0.28 0.01 3.70% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Theralase Technologies Performance and Theralase Technologies Correlation. Theralase |
Cross Equities Price To Sales Ratio Analysis
Compare Theralase Technologies and related stocks such as VentriPoint Diagnostics, Theralase Technologies, and Sirona Biochem Corp Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VPT | 102 | 102 | 43.2856 | 138 | 77.7316 | 106 | 15.7555 | 364 | 148 | 62.5746 | 186 | 618 | 618 | 941 | 847 | 889 |
| RHT | 1 K | 1 K | 1 K | 1 K | 1 K | 165 | 577 | 73.9825 | 169 | 31.9408 | 52.3725 | 10.1693 | 183 | 183 | 210 | 279 |
| MBX | 7.1822 | 2.8784 | 1.3189 | 4.9288 | 3.5541 | 2.1348 | 3.0769 | 1.8377 | 1.7352 | 2.5899 | 3.8914 | 3.6193 | 2.5888 | 2.5888 | 2.98 | 5.07 |
Theralase Technologies and related stocks such as VentriPoint Diagnostics, Theralase Technologies, and Sirona Biochem Corp Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Theralase Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Theralase Technologies sales, a figure that is much harder to manipulate than other Theralase Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Theralase Technologies | TLT |
| Classification | IT |
| Business Address | 41 Hollinger Road, |
| Exchange | TSX Venture Exchange |
CAD 0.28
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.